改善严重肌痛性骨髓灰质炎和吉兰-巴雷综合征的治疗结果
Maximiliano A Hawkes1, Eelco F M Wijdicks1
1Department of Neurology, Neurocritical Care Services, Mayo Clinic, Rochester, Minnesota.
Seminars in neurology
|April 1, 2024
概括
严重的骨髓灰质炎和吉兰-巴雷综合征可能是致命的,主要是由于需要机械通风的呼吸衰竭. 专家神经临床护理对于管理这些疾病和改善患者的治疗结果至关重要.
科学领域:
- 神经学 神经学
- 关键护理医学 关键护理医学
背景情况:
- 骨髓灰质炎和吉兰-巴雷综合征是严重的神经肌肉疾病.
- 渐进的衰弱会导致呼吸衰竭和预后不佳.
研究的目的:
- 为了比较肌痛性骨髓灰质炎和吉-巴雷综合征的临床结果和预后因素.
- 突出神经临床护理在管理这些衰弱性疾病中的作用.
主要方法:
- 临床课程的比较分析.
- 对预后指标的审查,重点是呼吸衰竭和机械通风.
- 评估治疗复杂性和恢复模式.
主要成果:
- 耳肌肉衰弱和需要机械通风的呼吸衰竭是这两种情况预后不佳的关键因素.
- 骨髓灰质炎患者通常需要免疫抑制,并伴有相关风险.
- 吉兰-巴雷综合征通常具有长期但往往有利的恢复,即使在严重的情况下.
结论:
- 专家神经临床护理显著影响了患有骨髓质疏松症和吉-巴雷综合征的患者的结果.
- 虽然这两种疾病都有不良预后的共同驱动因素,但恢复轨迹不同.
- 管理策略必须解决特定疾病的复杂性和风险.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests
819
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
819
Disorders of the Skeletal Muscle
941
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
941
Skeletal Muscle Relaxants: Therapeutic Uses
482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482
Skeletal Muscle Relaxants: Adverse Effects
367
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
367


